Clinical Trials Browser

OTHER × Genistein × Genitourinary × Clear all

Urinary Bladder Neoplasms

NCT02624388 2024-05-06

UVA-Gen001

Brain Neoplasms, Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin, Medulloblastoma, Neoplasms, Neoplasms, Germ Cell and Embryonal, Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Neuroectodermal Tumors, Primitive

NCT02766478 2022-09-27

GeniPro

Phase 2 Terminated

10 enrolled 10 charts

Genitourinary

Prostatic Neoplasms

NCT00769990 2017-12-13

Genistein in Treating Patients Undergoing External-Beam Radiation Therapy for Bone Metastases

Phase 1/2 Withdrawn

BreastDermatologicGenitourinaryThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Kidney Neoplasms, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Pain, Prostatic Neoplasms, Small Cell Lung Carcinoma

NCT00058266 2012-07-19

Genistein in Treating Patients With Localized Prostate Cancer Who Are Planning to Undergo Radical Prostatectomy

Phase 2 Terminated

36 enrolled

Genitourinary

Prostatic Neoplasms

NCT00005827 2012-04-24

Genistein in Treating Patients With Stage II, Stage III, or Stage IV Prostate Cancer

Phase 1 Withdrawn

Genitourinary

Prostatic Neoplasms

NCT00546039 2008-09-30

Synthetic Genistein (BONISTEIN™) in Patients Who Are Undergoing Surgery for Prostate Cancer

Phase 2 Unknown

47 enrolled

Genitourinary

Prostatic Neoplasms

Clinical Trials

Study of Genistein in Reducing Side Effects of Superficial Bladder Cancer Treatment

UVA-Gen001

GeniPro

Genistein in Treating Patients Undergoing External-Beam Radiation Therapy for Bone Metastases

Genistein in Treating Patients With Localized Prostate Cancer Who Are Planning to Undergo Radical Prostatectomy

Genistein in Treating Patients With Stage II, Stage III, or Stage IV Prostate Cancer

Synthetic Genistein (BONISTEIN™) in Patients Who Are Undergoing Surgery for Prostate Cancer